Literature DB >> 3976174

Susceptibility of North Ronaldsay sheep to copper from cupric oxide needles.

D P Britt, G H Yeoman.   

Abstract

Three housed North Ronaldsay sheep were treated with copper in the form of cupric oxide "needles", two at the manufacturer's recommended dosage rate and the third at twice this level. Sheep of this breed are especially sensitive to high dietary intake of copper. Pre- and post-dosing blood samples were monitored for changes in packed cell volume and changes in content of plasma copper, bilirubin, AST and SDH. Weight changes were also recorded. The animal dosed at twice the recommended level died on day 19 post-dosing of acute copper poisoning. The two dosed at the standard rate remained healthy and put on weight steadily throughout the six months following treatment. Two Welsh Mountain sheep dosed at the standard rate and maintained and examined in the same way likewise showed no signs of copper toxicity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976174     DOI: 10.1007/bf02215128

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  4 in total

1.  Predicting the effects of dietary molybdenum and sulphur on the availability of copper to ruminants.

Authors:  N F Suttle; M McLauchlin
Journal:  Proc Nutr Soc       Date:  1976-05       Impact factor: 6.297

2.  Deaths from copper toxicity of sheep at pasture and the use of fresh seaweed.

Authors:  G Wiener; A C Field; C Smith
Journal:  Vet Rec       Date:  1977-11-19       Impact factor: 2.695

3.  Use of cupric oxide needles in the prophylaxis of induced copper deficiency in lambs grazing improved hill pastures.

Authors:  A Whitelaw; A J Russel; R H Armstrong; C C Evans; A R Fawcett; A J MacDonald
Journal:  Vet Rec       Date:  1983-04-16       Impact factor: 2.695

4.  Copper poisoning in sheep from North Ronaldsay maintained on a diet of terrestrial herbage.

Authors:  G K MacLachlan; W S Johnston
Journal:  Vet Rec       Date:  1982-09-25       Impact factor: 2.695

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.